Protein kinase C-dependent upregulation of N-cadherin expression by phorbol ester in human calvaria osteoblasts

Exp Cell Res. 2001 Sep 10;269(1):154-61. doi: 10.1006/excr.2001.5301.

Abstract

Cell-cell adhesion mediated by cadherins is believed to play an essential role in the control of cell differentiation and tissue formation. Our recent studies indicate that N-cadherin is involved in human osteoblast differentiation. However, the signalling molecules that regulate cadherins in osteoblasts are not known. We tested the possibility that N-cadherin expression and function may be regulated by direct activation of protein kinase C (PKC) in human osteoblasts. Treatment of immortalized human neonatal calvaria (IHNC) cells with phorbol 12,13-dibutyrate (100 nM) transiently increased PKC activity. RT-PCR analysis showed that transient treatment with phorbol ester transiently increased N-cadherin mRNA levels at 4-12 h. Western blot analysis showed that N-cadherin protein levels were increased by phorbol ester at 24-48 h, and this was confirmed by immunocytochemical analysis. In contrast, E-cadherin expression was not affected. Transient treatment of IHNC cells with phorbol ester increased cell-cell aggregation, which was suppressed by neutralizing N-cadherin antibody, showing that the increased N-cadherin induced by phorbol ester was functional. Finally, phorbol ester dose-dependently increased alkaline phosphatase activity, an early marker of osteoblast differentiation. This effect was comparable to the promoting effect of BMP-2, a potent activator of osteoblast differentiation. These data show that direct activation of PKC by phorbol ester increases N-cadherin expression and function, and promotes ALP activity in human calvaria osteoblasts, which provides a signaling mechanism by which N-cadherin is regulated and suggests a role for PKC in N-cadherin-mediated control of human osteoblast differentiation.

MeSH terms

  • Alkaline Phosphatase / drug effects
  • Alkaline Phosphatase / metabolism
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins / pharmacology
  • Cadherins / drug effects
  • Cadherins / genetics
  • Cadherins / metabolism*
  • Carcinogens / pharmacology
  • Cell Adhesion / drug effects
  • Cell Adhesion / physiology*
  • Cell Aggregation / drug effects
  • Cell Aggregation / physiology
  • Cell Communication / drug effects
  • Cell Communication / physiology*
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology*
  • Cell Line, Transformed / cytology
  • Cell Line, Transformed / drug effects
  • Cell Line, Transformed / enzymology
  • Gene Expression / drug effects
  • Gene Expression / physiology
  • Humans
  • Infant, Newborn
  • Osteoblasts / cytology
  • Osteoblasts / drug effects
  • Osteoblasts / enzymology*
  • Phorbol Esters / pharmacology
  • Protein Kinase C / drug effects
  • Protein Kinase C / metabolism*
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Skull / cytology
  • Skull / drug effects
  • Skull / enzymology
  • Transforming Growth Factor beta*
  • Up-Regulation / drug effects
  • Up-Regulation / physiology*

Substances

  • BMP2 protein, human
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins
  • Cadherins
  • Carcinogens
  • Phorbol Esters
  • RNA, Messenger
  • Transforming Growth Factor beta
  • Protein Kinase C
  • Alkaline Phosphatase